EP Patent

EP2177510A1 — Allosteric protein kinase modulators

Assigned to Universitaet des Saarlandes · Expires 2010-04-21 · 16y expired

What this patent protects

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, …

USPTO Abstract

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

Drugs covered by this patent

Patent Metadata

Patent number
EP2177510A1
Jurisdiction
EP
Classification
—
Expires
2010-04-21
Drug substance claim
No
Drug product claim
No
Assignee
Universitaet des Saarlandes
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.